Logo image of LFST.CA

LIFEIST WELLNESS INC (LFST.CA) Stock Fundamental Analysis

TSX-V:LFST - CA53228D2059 - Common Stock

0.09 CAD
+0.02 (+28.57%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

3

LFST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 1 industry peers in the Distributors industry. While LFST has a great health rating, there are worries on its profitability. LFST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year LFST has reported negative net income.
LFST had a negative operating cash flow in the past year.
LFST had negative earnings in each of the past 5 years.
In the past 5 years LFST always reported negative operating cash flow.
LFST.CA Yearly Net Income VS EBIT VS OCF VS FCFLFST.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of LFST (-55.78%) is better than 100.00% of its industry peers.
LFST has a Return On Equity of -76.62%. This is amongst the best in the industry. LFST outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA -55.78%
ROE -76.62%
ROIC N/A
ROA(3y)-69.42%
ROA(5y)-67.58%
ROE(3y)-186.48%
ROE(5y)-148.09%
ROIC(3y)N/A
ROIC(5y)N/A
LFST.CA Yearly ROA, ROE, ROICLFST.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

LFST's Gross Margin of 71.38% is amongst the best of the industry. LFST outperforms 100.00% of its industry peers.
LFST's Gross Margin has improved in the last couple of years.
LFST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.09%
GM growth 5Y33.77%
LFST.CA Yearly Profit, Operating, Gross MarginsLFST.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFST has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LFST has been reduced compared to 5 years ago.
LFST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFST.CA Yearly Shares OutstandingLFST.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LFST.CA Yearly Total Debt VS Total AssetsLFST.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -87.60, we must say that LFST is in the distress zone and has some risk of bankruptcy.
LFST's Altman-Z score of -87.60 is amongst the best of the industry. LFST outperforms 100.00% of its industry peers.
There is no outstanding debt for LFST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -87.6
ROIC/WACCN/A
WACC9.33%
LFST.CA Yearly LT Debt VS Equity VS FCFLFST.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

LFST has a Current Ratio of 2.83. This indicates that LFST is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.83, LFST belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
LFST has a Quick Ratio of 2.42. This indicates that LFST is financially healthy and has no problem in meeting its short term obligations.
LFST has a Quick ratio of 2.42. This is amongst the best in the industry. LFST outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.42
LFST.CA Yearly Current Assets VS Current LiabilitesLFST.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

3. Growth

3.1 Past

LFST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.98%, which is quite impressive.
Looking at the last year, LFST shows a very negative growth in Revenue. The Revenue has decreased by -56.86% in the last year.
Measured over the past years, LFST shows a very negative growth in Revenue. The Revenue has been decreasing by -48.56% on average per year.
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.79%
Revenue 1Y (TTM)-56.86%
Revenue growth 3Y-69.69%
Revenue growth 5Y-48.56%
Sales Q2Q%-99.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LFST.CA Yearly Revenue VS EstimatesLFST.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
LFST.CA Yearly EPS VS EstimatesLFST.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFST.CA Price Earnings VS Forward Price EarningsLFST.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFST.CA Per share dataLFST.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LFST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIFEIST WELLNESS INC

TSX-V:LFST (8/29/2025, 7:00:00 PM)

0.09

+0.02 (+28.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-28 2025-10-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.67%
Ins Owner ChangeN/A
Market Cap3.41M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.79
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB 1.92
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.02
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.78%
ROE -76.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.38%
FCFM N/A
ROA(3y)-69.42%
ROA(5y)-67.58%
ROE(3y)-186.48%
ROE(5y)-148.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.09%
GM growth 5Y33.77%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -1.82%
Cap/Sales 0.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 2.42
Altman-Z -87.6
F-Score4
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)27.07%
Cap/Depr(5y)51.27%
Cap/Sales(3y)1.52%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-56.86%
Revenue growth 3Y-69.69%
Revenue growth 5Y-48.56%
Sales Q2Q%-99.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.92%
OCF growth 3YN/A
OCF growth 5YN/A